SCHEMBL17961069

SCHEMBL17961069

CCCCCOc1ccccc1CCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 1/20 0.55
LTB4R Q15722 1/20 0.55
LTB4R2 Q9NPC1 1/20 0.55
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
MAPT P10636 3/20 0.50
ADRA2A P08913 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MEN1 O00255 1/20 0.50
NR1I2 O75469 1/20 0.50
LMNA P02545 1/20 0.50
CHRM2 P08172 1/20 0.50
CYP3A4 P08684 1/20 0.50
OPRK1 P41145 1/20 0.50
HTR2B P41595 1/20 0.50
SLC6A3 Q01959 1/20 0.50
KMT2A Q03164 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7999552 0.94 PPARD (0.60) PPARDLTB4RLTB4R2CYP1A2CYP2C9
SCHEMBL8523169 0.92 LTB4R (0.55) PPARDLTB4RLTB4R2CYP1A2CYP2C9
SCHEMBL11341195 0.91 LTB4R (0.53) PPARDLTB4RLTB4R2CYP1A2CYP2C9
SCHEMBL11043183 0.91 LTB4R (0.57) LTB4RLTB4R2CYP1A2CYP2C9CYP2C19
SCHEMBL6549162 0.91 LTB4R (0.57) LTB4RLTB4R2CYP1A2CYP2C9CYP2C19
SCHEMBL6547809 0.91 LTB4R (0.57) LTB4RLTB4R2CYP1A2CYP2C9CYP2C19
SCHEMBL9489161 0.91 LTB4R (0.57) LTB4RLTB4R2CYP1A2CYP2C9CYP2C19
SCHEMBL6550074 0.91 LTB4R (0.57) LTB4RLTB4R2CYP1A2CYP2C9CYP2C19
SCHEMBL16933732 0.91 LTB4R (0.53) PPARDLTB4RLTB4R2CYP1A2CYP2C9
SCHEMBL6550542 0.91 LTB4R (0.57) LTB4RLTB4R2CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160221921-A1 SKIN WHITENING AGENT CONTAINING NOVEL CYCLIC COMPOUND RNS CO.,LTD. (KR) 2016-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221921-A1 SKIN WHITENING AGENT CONTAINING NOVEL CYCLIC COMPOUND H1-10, HCN1, HCN4 PPARD 3668/4885LTB4R 1039/4885LTB4R2 1264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.